Harvard Bioscience, Inc. HBIO
7.96
(0.06)
(0.75%)
as of 25 Sep
- Market cap
- $36.5M
- P/E
- 0.0×
Follow HBIO
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.34 | 0.98 | 2.04 | 0.98 | 2.39 | 1.62 | 0.99 | 0.96 | 1.48 | 0.95 |
P/FCF ratio |
6.11 | 0.00 | 18.70 | 0.00 | 0.00 | 20.27 | 16.89 | 61.08 | 640.70 | 25.19 |
P/Operating CF |
(309.81) | 53.26 | 53.14 | 41.43 | 2,430.92 | 66.57 | 51.95 | 44.71 | (122.14) | 57.45 |
P/B ratio |
2.17 | 1.45 | 3.13 | 1.54 | 3.41 | 2.16 | 1.41 | 1.40 | 1.42 | 1.37 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.45 | 6.41 |
EV/Sales |
1.05 | 1.69 | 2.32 | 1.35 | 2.73 | 2.01 | 1.38 | 1.40 | 1.57 | 1.03 |
EV/EBITDA |
13.70 | 124.87 | 28.45 | 166.27 | 32.60 | 22.75 | 18.93 | 17.77 | 37.77 | 78.48 |
EV/Operating CF |
13.52 | 110.39 | 18.60 | 133.08 | 257.47 | 22.02 | 19.99 | 58.44 | 114.70 | 19.95 |
EV/FCF |
18.69 | (87.20) | 21.34 | (260.72) | (3,914.78) | 25.12 | 23.55 | 88.80 | 677.32 | 27.26 |
Quick Ratio |
1.12 | 0.35 | 0.77 | 0.91 | 1.17 | 1.24 | 1.15 | 1.16 | 1.59 | 1.75 |
Current Ratio |
2.20 | 0.82 | 1.85 | 2.20 | 2.43 | 2.46 | 2.12 | 2.27 | 3.39 | 3.11 |
Net Debt/EBITDA |
4.11 | 25.80 | 3.52 | 45.90 | 4.06 | 4.39 | 5.35 | 5.55 | 2.04 | 5.96 |
Debt/Assets |
44.80% | 29.18% | 26.62% | 32.21% | 29.77% | 30.72% | 32.64% | 36.06% | 10.74% | 12.76% |
Debt/Equity |
2.61 | 0.58 | 0.50 | 0.65 | 0.58 | 0.63 | 0.66 | 0.73 | 0.15 | 0.19 |
Asset Turnover |
0.84 | 0.71 | 0.79 | 0.74 | 0.75 | 0.64 | 0.70 | 0.87 | 0.71 | 0.92 |
Operating CF/Net income |
(0.12) | (0.12) | (4.11) | (0.12) | (4.38) | (1.19) | (1.72) | (0.99) | (1.22) | (1.25) |
Capex/Depreciation |
(0.03) | (0.44) | (0.25) | (0.20) | (0.17) | (0.16) | (0.15) | (0.12) | (0.23) | (0.33) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (147.13%) | (18.19%) | (4.70%) | (12.23%) | (0.36%) | (9.86%) | (5.70%) | (3.57%) | (1.13%) | (5.75%) | |
| (54.86%) | (9.40%) | (2.42%) | (6.19%) | (0.18%) | (4.86%) | (2.81%) | (2.10%) | (0.80%) | (3.78%) | |
ROIC |
(74.07%) | (4.04%) | 1.12% | (3.78%) | 1.04% | 0.12% | 0.19% | 0.45% | (0.45%) | (2.33%) |
Return on Tangible Assets |
(182.60%) | 261.99% | (12.90%) | (30.46%) | (0.73%) | (22.57%) | (14.19%) | (7.64%) | (2.32%) | (12.25%) |
Average Days of Receivables |
67.66 | 57.64 | 52.35 | 53.80 | 67.02 | 63.51 | 65.05 | 64.86 | 80.59 | 69.57 |
Research and Development Expense of Revenue |
10.20% | 11.05% | 10.48% | 10.88% | 9.08% | 8.51% | 9.22% | 9.10% | 7.29% | 5.16% |
Selling, General and Administrative Expense of Revenue |
42.70% | 46.43% | 41.71% | 43.71% | 41.17% | 42.53% | 39.62% | 37.94% | 42.12% | 39.64% |
Intangible Assets out of Total Assets |
0.21 | 0.53 | 0.53 | 0.53 | 0.52 | 0.59 | 0.58 | 0.61 | 0.44 | 0.53 |
Share Based Compensation of Revenue |
2.14% | 4.61% | 4.45% | 3.89% | 3.51% | 3.57% | 2.61% | 2.52% | 4.52% | 3.35% |
Graham Net Nets |
(0.61) | (0.20) | (0.07) | (0.20) | (0.06) | (0.17) | (0.26) | (0.24) | 0.17 | 0.10 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(191.04%) | (13.74%) | (1.40%) | (8.58%) | (0.20%) | (4.78%) | (4.00%) | (3.05%) | (0.61%) | (4.48%) |
Free Cash Flow Yield |
16.36% | (1.98%) | 5.35% | (0.53%) | (0.03%) | 4.93% | 5.92% | 1.64% | 0.16% | 3.97% |
Revenue per Share |
19.50 | 21.62 | 26.46 | 27.37 | 29.47 | 26.42 | 30.72 | 33.13 | 22.27 | 30.55 |
Operating CF per Share |
1.52 | 0.33 | 3.31 | 0.28 | 0.31 | 2.41 | 2.13 | 0.79 | 0.30 | 1.57 |
Capex per Share |
(0.42) | (0.75) | (0.42) | (0.38) | (0.33) | (0.36) | (0.32) | (0.27) | (0.25) | (0.42) |
Free Cash Flow per Share |
1.10 | (0.42) | 2.88 | (0.11) | (0.02) | 2.05 | 1.81 | 0.52 | 0.05 | 1.15 |
Cash per Share |
1.94 | 0.94 | 1.01 | 1.09 | 1.94 | 2.15 | 2.20 | 2.24 | 1.49 | 1.64 |
Shareholders Equity per Share |
3.09 | 14.55 | 17.23 | 17.44 | 20.67 | 19.85 | 21.60 | 22.69 | 23.28 | 21.10 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.09 | 14.55 | 17.23 | 17.44 | 20.67 | 19.85 | 21.60 | 22.69 | 23.28 | 21.10 |
Free Cash Flow |
4.87 | (1.82) | 12.23 | (0.44) | (0.08) | 7.93 | 6.83 | 1.90 | 0.18 | 3.94 |
Working Capital |
26.27 | (9.84) | 22.50 | 27.88 | 36.27 | 30.65 | 28.26 | 32.34 | 33.49 | 30.87 |
Capital Expenditures |
(1.86) | (3.26) | (1.80) | (1.59) | (1.34) | (1.40) | (1.22) | (0.99) | (0.88) | (1.44) |
Net Current Asset Value |
(18.11) | (18.19) | (15.25) | (22.02) | (17.36) | (27.87) | (29.60) | (28.06) | 19.08 | 9.90 |
EV/EBIT |
0.00 | 0.00 | 137.76 | 0.00 | 157.27 | 929.66 | 426.56 | 171.28 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Net Profit Margin |
(65.51%) | (13.18%) | (3.04%) | (8.40%) | (0.24%) | (7.65%) | (4.03%) | (2.42%) | (1.12%) | (4.12%) |
Price to Operating Income |
0.00 | 0.00 | 120.72 | 0.00 | 137.67 | 750.07 | 305.92 | 117.81 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
11.54 | 1.47 | 1.83 | 2.33 | 2.31 | 2.23 | 1.70 | 1.44 | 1.03 | 1.02 |
Cash ROIC |
3.34% | (3.51%) | 8.82% | (1.79%) | (1.54%) | 4.04% | 2.27% | (1.99%) | (2.75%) | 1.19% |
Accounts Receivable Turnover |
5.60 | 6.08 | 6.84 | 5.88 | 6.01 | 5.31 | 5.51 | 6.27 | 4.18 | 5.06 |
Accounts Payable Turnover |
8.68 | 7.61 | 7.70 | 9.25 | 9.42 | 7.79 | 8.17 | 9.79 | 7.21 | 7.49 |
Inventory Turnover |
1.66 | 1.64 | 1.81 | 1.94 | 2.06 | 1.99 | 2.20 | 2.75 | 2.08 | 2.65 |
Average Days of Payables |
36.38 | 44.38 | 43.90 | 44.81 | 34.97 | 49.47 | 37.58 | 46.64 | 42.10 | 40.31 |
Days of Inventory on Hand |
207.26 | 215.51 | 195.36 | 183.76 | 196.47 | 184.43 | 155.29 | 158.99 | 160.83 | 129.82 |
Average Receivables |
15.45 | 15.48 | 16.40 | 19.27 | 19.80 | 19.24 | 21.08 | 19.28 | 18.51 | 20.67 |
Average Payables |
4.22 | 5.17 | 6.00 | 5.68 | 5.44 | 5.66 | 6.35 | 5.88 | 5.30 | 7.49 |
Average Inventory |
22.03 | 23.98 | 25.58 | 27.01 | 24.92 | 22.16 | 23.57 | 20.97 | 18.40 | 21.15 |
Average Assets |
103.36 | 132.01 | 141.36 | 153.85 | 159.30 | 160.56 | 166.74 | 138.98 | 108.56 | 113.91 |
Average Common Equity |
38.54 | 68.21 | 72.65 | 77.81 | 80.04 | 79.19 | 82.21 | 81.81 | 76.55 | 74.90 |
Columns are period end dates